Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients (CHRU01)

This study has been terminated.
(DSMB decision to begin closeout process in view of April 2010 SA HAART guideline)
Information provided by (Responsible Party):
Colin Menezes, University of Witwatersrand, South Africa Identifier:
First received: May 14, 2012
Last updated: May 16, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)